Site-specific lysine 295 (K295) was substituted for glutamine (K295Q) in FOXA1, a critical transcription factor involved in the signaling of the estrogen and androgen receptors in MCF-7 Luminal A breast cancer cells. Here, FOXA1 is linked to breast cancer.